The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
IN8bio, Inc.(NASDAQ:INAB) 
IN8bio, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of gamma-delta T cell therapies for the treatment of cancers. The company develops INB-200, a genetically modified autologous gamma-delta T cell product candidate that is in Phase I cli...
Share this website to your friends
IN8bio . Days Payable Outstanding ttm (DPO)
IN8bio . Op Cashflow Per Share ttm
IN8bio . Free Cashflow Per Share ttm
IN8bio . Cash Per Share ttm
IN8bio . (GAAP) P/E ratio ttm
IN8bio . P/B ratio ttm
No extra charts and metrics for this ticker.